Covestor LTD Amgen Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Amgen Inc stock. As of the latest transaction made, Covestor LTD holds 457 shares of AMGN stock, worth $120,871. This represents 0.09% of its overall portfolio holdings.

Number of Shares

457

Previous 1,110 58.83%

Holding current value

$120,871

Previous $348,000 57.47%

% of portfolio

0.09%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $202,025 - $220,309	-653 Reduced 58.83%	457 $148,000
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $87,495 - $106,330	333 Added 42.86%	1,110 $348,000
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $48,127 - $58,096	-179 Reduced 18.72%	777 $220,000
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $25,314 - $28,557	-99 Reduced 9.38%	956 $274,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $73,247 - $90,939	335 Added 46.53%	1,055 $283,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $18,641 - $22,043	87 Added 13.74%	720 $160,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $1,354 - $1,651	-6 Reduced 0.94%	633 $153,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $687 - $873	-3 Reduced 0.47%	639 $167,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $50,279 - $56,705	-224 Reduced 25.87%	642 $145,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 2.26%	866 $211,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $74,113 - $81,988	338 Added 61.68%	886 $214,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $108,986 - $124,724	548 New	548 $123,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account